Login
R1 RCM Inc. logo

R1 RCM Inc.

r1rcm.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2024 10-Q, filed Nov 5, 2024. Its latest SEC filing is a 15-12G from Nov 29, 2024.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Manages medical billing, claims and collections and provides related technology to health systems, hospitals and physician groups.

How Did They Make Money?

Healthcare providers pay R1 for outsourced billing and collection work. For full-service contracts, base fees are billed before each quarter and paid monthly as services are provided; performance fees are typically paid quarterly, while some modular fees are billed after customers collect additional revenue.

FY2023 revenue by product or service revenue
SegmentShareRevenue
Net operating fees
65%
FY2020: 86%
Incentive fees
4.8%
FY2020: 5.6%
Other
31%
FY2020: 8.4%

Who Were Their Customers?

Customers are health systems, hospitals and physician groups. R1's sales teams work directly with prospective health systems and expand existing customer relationships.

Customers above 10% of revenue, FY2023
of revenue from one customer
FY2021: 61% from one customer

Did Revenues Turn Into Profits?

Yes. It kept less than a cent of every revenue dollar as net income in FY2023 and turned 11 cents into free cash flow.

Operating income, FY2023
7% of revenue
▲ Turned profitable vs FY2022 (−$2.8M, 0%)
Net income, FY2023
0% of revenue
▲ Turned profitable vs FY2022 (−$63.3M, −4%)
Free cash flow, FY2023
11% of revenue
▲ Turned profitable vs FY2022 (−$103.4M, −6%)

How Were They Changing?

Since the FY2023 annual report
Latest quarter: Q3 FY2024, the three months to Sep 30, 2024
Revenue
▲ +15%
vs $572.8M in Q3 FY2023
Net income
▼ Turned to a loss
vs $1.3M in Q3 FY2023
Net operating fees share of revenue vs 64.3% in Q3 FY2023
  • Nov 19, 2024 TowerBrook and CD&R completed R1's acquisition and took it private Joe Flanagan replaced Lee Rivas as CEO, and R1's shares ceased trading on Nasdaq.
  • Aug 1, 2024 R1 agreed to be acquired by TowerBrook and CD&R The buyers agreed to acquire shares TowerBrook did not own for $14.30 per share in cash.
  • May 8, 2024 R1 updated its full-year 2024 outlook It forecast revenue of $2.60 billion to $2.64 billion and operating income of $85 million to $105 million.
Revenue over time
Net operating fees Incentive fees Other
$2.5B$1.3B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support